Chabiotech Co.,Ltd.

As of Aug 31, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

How to read this grade

SABCDCurrentF

Toward S means a higher total-score band; toward F, a lower band. Badges are distinguished by ink intensity and shape (fill, outline, dashed) — never by hue.

Maegim maps a total score — built from sector-relative percentile scoring — onto fixed, predefined thresholds to assign one of six bands, S to F. This stock is scored by the same formula as all 2,523 graded stocks and is currently in band D with a total score of 36.3 points.

How grades are computed →What grades do and don’t mean →What the grade does not reflect →

Position within sector

Mechanically selected indicators in the top or bottom 30% of sector percentiles · among 250 stocks in Pharma & Biotech

Upper percentile

Top 21.7% in sector — Revenue 3-year CAGRGrowth momentum →Top 22.5% in sector — Revenue growth (YoY)Growth momentum →

Lower percentile

Bottom 8.3% in sector — Debt-to-equity ratioFinancial strength →Bottom 13.6% in sector — Current ratioFinancial strength →Bottom 21.7% in sector — ROE (return on equity)Financial strength →

1-year closing price

Low ₩8,030High ₩23,850

Latest close

Price change by period

0.40%

4.40%

40.00%

21.40%

As of the Aug 31, 2026 close · updated once daily · a factual record computed from closing prices only; dividends are not included, and this is not a buy or sell signal.

Financial strength

22.7/100

How much debt does it carry relative to equity?

214.8%

Sector median 51.6%

Sector low

highBottom 8.3% in sector

Can it cover what's due within a year?

67.1%

Sector median 191.7%

Sector low

highBottom 13.6% in sector

How much of revenue becomes profit?

-3.8%

Sector median -2.4%

Sector low

highBottom 47.3% in sector

How much did it earn on its own capital?

-36.1%

Sector median -4.5%

Sector low

highBottom 21.7% in sector

Source filing: annual report (consolidated) — view original ↗

Growth momentum

65.8/100

How much did revenue grow in a year?

21.4%

Sector median 6.4%

Sector low

highTop 22.5% in sector

Has it grown steadily over three years?

14.5%

Sector median 4.9%

Sector low

highTop 21.7% in sector

Did core profits grow in a year?

18.3%

Sector median 3.6%

Sector low

highTop 38% in sector

Are core profits higher than three years ago?

-3.6%

Sector median 3.5%

Sector low

highBottom 45.4% in sector

Financial trend

Revenue

Growth & margin

Revenue growth Operating margin

Year over year — alongside the sector median

This stock Sector median

A factual chart of confirmed annual results from annual reports — the same source as the grading indicators. Not a buy or sell signal.

Source filing: annual report (consolidated) — view original ↗

Price attractiveness

30.6/100

Is the price expensive relative to earnings?

Loss-making (P/E not computable)

Sector median P/E of profitable peers 16.1x · 58% loss-making

Sector low

highBottom 22.5% in sector

Is the price expensive relative to book value?

2.46x

Sector median 1.59x

Sector low

highBottom 38.7% in sector

Valuation uses the Aug 31, 2026 close and market cap

Shareholder Return

Single-indicator axis37.5/100

Does the company actually pay dividends?

0.0%

Sector median 0.0%

Sector low

highBottom 37.5% in sector

Source filing: annual report (consolidated) — view original ↗

Financial checklist

Based on the FY2025 annual report · year-over-year comparison · determined on Sep 1, 2026

Of 9 items: 2 met · 7 not met · 0 not computable

Not metMetNot computable

Positive net income

Whether net income (attributable to owners where available) is above zero.

Not met

-₩109.9B

Positive operating cash flow

Whether cash flow from operations is above zero.

Not met

-₩72.5B

Return on assets up

Whether net income over beginning total assets rose from the prior year.

Not met

-0.5% → -5.0%

Operating cash flow exceeds net income

Whether operating cash flow is greater than net income.

Met

-₩72.5B vs -₩109.9B

Liabilities-to-assets ratio down

Whether total liabilities as a share of total assets fell from the prior year.

Not met

67.2% → 68.2%

Current ratio up

Whether current assets over current liabilities rose from the prior year.

Not met

71.9% → 67.1%

Shares outstanding not increased

Whether common shares issued did not increase from the prior year. Increases from bonus issues and stock dividends are also counted.

Not met

56,314,443 → 79,302,375

Operating margin up

Whether operating income over revenue rose from the prior year.

Met

-5.7% → -3.8%

Asset turnover up

Whether revenue over beginning total assets rose from the prior year.

Not met

0.61x → 0.58x

A record of facts determined by fixed rules from the financial statements in the latest annual report. Not used in grading, and not a buy or sell signal. Source filing: annual report (consolidated) — view original ↗

Grade change history

Jul 23, 2026D

Methodology version change (v2.0 applied)

Jul 15, 2026DVersion v1

First calculation

Grade changes are a factual record produced from public data by a fixed formula; they do not signal future changes.

Disclosure & financial badges

Factual records determined from public filings and periodic reports by fixed rules — not buy/sell signals.

Negative-evidence group (dilution, loss, dispute)Mixed interpretationPositive-evidence group (shareholder return)Dots classify the disclosure type by the direction of research evidence — not an assessment or investment judgment about this company.

Disclosure event history

Private CB/BW issuance resolutions (past 36 months)

2 private-placement convertible bond (CB) / bond-with-warrants (BW) issuance resolutions were disclosed in the past 36 months (latest filing 2025-06-19). View filing ↗

CB with conversion-price adjustment clause (past 36 months)

1 convertible bond (CB) issuance resolutions including a downward conversion-price adjustment (refixing) clause were disclosed in the past 36 months (latest filing 2025-06-19). View filing ↗

CEO (representative executive officer) change filings (past 36 months)

3 CEO (representative executive officer) change filings were submitted in the past 36 months (latest filing 2026-03-04). View filing ↗

Financial fact combinations

Operating losses for 3 consecutive fiscal years

Recorded operating losses in three consecutive fiscal years, FY2023–FY2025 (per annual reports).

Determined as of 2026-09-01

Recent filings for this stock

Last 120 days · monitored filing types only

Periodic report filedAug 13, 2026Source ↗

Periodic report filedMay 15, 2026Source ↗

View in the filings calendar →